fbpx

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

All posts by David Emerson

Myeloma- Chemotherapy-induced Bladder Damage

“These results suggest that taurine offers a protective effect against CP-induced urinary bladder damage… Moringa leaves play an important role in ameliorating and protecting the bladder from

Continue reading

Myeloma- Hyperbaric Oxygen Therapy Stem Cell Transplants

Hyperbaric Oxygen Therapy Stimulates Stem Cells, Heals Radiation Damage and may even Kill Cancer HBOT is an ideal multiple myeloma therapy for the newly diagnosed MM survivor about to undergo an ASCT and

Continue reading

High-dose Cytoxan- Chemobrain, Painful Bladder-

“Acute haemorrhagic cystitis occurs in 30 per cent of patients receiving high dose cyclophosphmide . The case highlights that late and severe haemorrhagic cystitis can develop even when cyclophasphamide

Continue reading

Multiple Myeloma Therapy- Whole-Body Hyperthermia (Sauna)

Whole-Body Hyperthermia (sauna) is cytotoxic to myeloma, lowers blood pressure, rids the body of heavy metals and is relaxing… Whole-Body Hyperthermia (sauna) is about as non-conventional a multiple

Continue reading

CBD Oil- Mental Health & Wellbeing

I am a long-term survivor of Multiple Myeloma, an incurable blood cancer. From the tine of my diagnosis in early 1994 until my oncologist told me “there is nothing more we can do for you, “

Continue reading

Chemo for High Risk Smoldering Myeloma- Pain…

“…among the lenalidomide-treated patients, grade 3 or 4 hematologic and nonhematologic adverse events occurred in 36 patients (41%), with nonhematologic adverse events occurring in 25 patients

Continue reading

Multiple Myeloma- MRD, Complete Remission?

Multiple Myeloma (MM) remission criteria can indicate the mm survivor’s prognosis. Let me explain- Remission… what does this mean? Should you attempt to reach minimal residual disease (MDR)

Continue reading

Myeloma Imaging- “MRI With Contrast” Gadolinium?

“Gadolinium (Gd)-based contrast agents are frequently used to enhance MRI resolution. We evaluated effect of the most common Gd-containing agent, Omniscan, on myeloma cells.” Multiple myeloma

Continue reading

Myeloma in the Elderly- Minimize Toxicity-Increase Non-Toxic Therapies

“Toxicity (for elderly Multiple Myeloma patients) is a significant concern, and doses of thalidomide and of myelotoxic agents should be reduced in patients who are older than 75 years or who have

Continue reading

DRd vs. VRd as induction therapy for NDMM?

This real-life survey indicates that re-treatment including bortezomib as a first salvage therapy could be still considered in MM patients achieving durable response after initial exposure to bortezomib

Continue reading

Myeloma- Revlimid- Blood Clot Despite Blood Thinners

Overall, a substantial risk of VTE associated with lenalidomide-based regimens (MM side effect) was evident in controlled clinical trial settings, despite adequate thromboprophylaxis.” You’ve

Continue reading

MGUS, SMM- Progression Risk

“What determines the risk of progression from asymptomatic to symptomatic myeloma…Most widespread and validated adversely predictive chromosomal aberrations (high-risk aberrations) in this

Continue reading